Nanomedicine Market (Neurology, Cardiovascular, Anti-inflammatory, Anti-infective, and Oncology Applications) - Global Industry Analysis, Size, Share,Growth, Trends and Forecast, 2013 - 2019

LONDON, May 21, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

Nanomedicine Market (Neurology, Cardiovascular, Anti-inflammatory, Anti-infective, and Oncology Applications) - Global Industry Analysis, Size, Share,Growth, Trends and Forecast, 2013 - 2019

http://www.reportbuyer.com/pharma_healthcare/drug_delivery/nanomedicine_market_neurology_cardiovascular_anti_inflammatory_anti_infective_oncology_applications_global_industry_analysis_size_share_growth_trends_forecast_2013_2019.html

This report includes market estimations for nanomedicine market for the forecast period 2013 - 2019. The market size is represented in terms of USD billion and the market estimates and forecasts are calculated, considering 2012 as the base year. Moreover, market trends and recent developments have been kept into account while forecasting market growth and revenue for the period 2013 - 2019.

The overall nanomedicine market is segmented on the basis of application and geography and the market estimations for each of these segments, in terms of USD billion, is provided in this report.

The nanomedicine market, by applications is segmented into neurological, cardiovascular, oncology, anti-inflammatory, anti-infective and other markets. The nanomedicine market is also estimated and analyzed on the basis of geographic regions such as North America, Europe, Asia-Pacific and rest of the world.

The global trends such as drivers, restraints and opportunities of the global nanomedicine market is detailed in the market overview chapter of this report., with a view on impact of these factors on market growth along the course of the forecast period.

The chapter on competitive landscape consists of heat map analysis of the key players operating in the global nanomedicine market. Some of the key players of this market include GE Healthcare, Mallinckrodt plc, Nanosphere Inc., Pfizer Inc., Merck & Co Inc., Celgene Corporation, CombiMatrix Corporation, Abbott Laboratories and others. The role of these market players in the global nanomedicine market is analyzed by profiling them on the basis of attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments.

The global nanomedicine market is categorized into the following segments:

Nanomedicine Market by Application

Neurology
Cardiovascular
Anti-Inflammatory
Anti-Infectives
Oncology
Others

Nanomedicine Market by Geography

North America
Europe
Asia-Pacific
Rest of the World (RoW)

Table of Content

Chapter 1 Preface
1.1 Report description
1.2 Research Methodology
1.3 Market Segmentation

Chapter 2 Executive Summary

Chapter 3 Global Nanomedicine Market Overview
3.1 Market Dynamics
3.1.1 Market Drivers
3.1.1.1 Improvement in technology for nanomedicine
3.1.1.2 Rising government support for research and development in nanomedicine
3.1.1.3 Presence of high unmet medical needs
3.1.1.4 Increase in investment amount and healthcare collaborations
3.1.1.5 High prevalence of chronic diseases
3.1.1.6 Impact Analysis of the Market Drivers
3.1.2 Market Restraints
3.1.2.1 Lack of organized regulatory framework
3.1.2.2 High costs involved
3.1.2.3 Impact Analysis of the Market Restraints
3.1.3 Market Opportunities
3.1.3.1 Presence of unmet medical needs in emerging economies
3.1.3.2 Identification of new medical applications
3.2 Porter's Five Forces Analysis: Global Nanomedicine Market
3.2.1 Bargaining Power of Suppliers
3.2.2 Bargaining Power of Buyers
3.2.3 Threat of New entrants
3.2.4 Threat of Substitutes
3.2.5 Competitive Rivalry
3.3 Market Attractiveness Analysis of the Global Nanomedicine Market, by Application
3.4 Global Nanomedicine Market, 2011 – 2019 (USD Million)

Chapter 4 Global Nanomedicine Market, by Applications
4.1 Overview
4.2 Nanomedicine for Neurology
4.2.1 Global Nanomedicine for Neurology Market, 2011 – 2019 (USD Billion)
4.3 Nanomedicine for Cardiovascular (CVS)
4.3.1 Global Nanomedicine for Cardiovascular Market , 2011 – 2019 (USD Billion)
4.4 Nanomedicine for Oncology
4.4.1 Global Nanomedicine for Oncology Market , 2011 – 2019 (USD Billion)
4.5 Nanomedicine for Anti-inflammatory
4.5.1 Global Nanomedicine for Anti-Inflammatory Market, 2011 – 2019 (USD Billion)
4.6 Nanomedicine for Anti-infectives
4.6.1 Global Nanomedicine for Anti-Infectives Market, 2011 – 2019 (USD Billion)
4.7 Other Applications
4.7.1 Global Nanomedicine Market for Other Applications, 2011 – 2019 (USD Billion)
4.8 Comparative Analysis: Global Nanomedicine Market by Applications, 2012 & 2019 (%)

Chapter 5 Global Nanomedicine Market, by Geography
5.1 Overview
5.1.1 Comparative Analysis of the Global Nanomedicine Market, by Geography, 2012 & 2019 (%)
5.2 North America
5.2.1 North America Nanomedicine Market, 2011 - 2019 (USD Billion)
5.3 Europe
5.3.1 Europe Nanomedicine Market, 2011 - 2019 (USD Billion)
5.4 Asia-Pacific
5.4.1 Asia-Pacific Nanomedicine Market, 2011 - 2019 (USD Billion)
5.5 Rest of the World
5.5.1 Rest of the World Nanomedicine Market, 2011 - 2019 (USD Billion)

Chapter 6 Recommendations
6.1 Collaborating with educational institutions to boost interdisciplinary education and training
6.2 Identifying and prioritizing key growth areas

Chapter 7 Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Overview
7.1.3 Product Portfolio
7.1.4 Business Strategies
7.1.5 Recent Developments
7.2 CombiMatrix Corporation
7.2.1 Company Overview
7.2.2 Financial Overview
7.2.3 Product Portfolio
7.2.4 Business Strategy
7.2.5 Recent Developments
7.3 Celgene Corporation
7.3.1 Company Overview
7.3.2 Financial Overview
7.3.3 Product Portfolio
7.3.4 Business Strategies
7.3.5 Recent Developments
7.4 Mallinckrodt plc.
7.4.1 Company Overview
7.4.2 Financial Overview
7.4.3 Product Portfolio
7.4.4 Business Strategies
7.4.5 Recent Developments
7.5 GE Healthcare
7.5.1 Company Overview
7.5.2 Financial Overview
7.5.3 Product Portfolio
7.5.4 Business Strategies
7.5.5 Recent Developments
7.6 Johnson & Johnson
7.6.1 Company Overview
7.6.2 Financial Overview
7.6.3 Product Portfolio
7.6.4 Business Strategies
7.6.5 Recent Developments
7.7 Merck & Company Inc.
7.7.1 Company Overview
7.7.2 Financial Overview
7.7.3 Product Portfolio
7.7.4 Business Strategies
7.7.5 Recent Developments
7.8 Nanosphere, Inc.
7.8.1 Company Overview
7.8.2 Financial Overview
7.8.3 Product Portfolio
7.8.4 Business Strategies
7.8.5 Recent Developments
7.9 Pfizer Inc.
7.9.1 Company Overview
7.9.2 Financial Overview
7.9.3 Product Portfolio
7.9.4 Business Strategies
7.10 Sigma-Tau Pharmaceuticals Inc.
7.10.1 Company Overview
7.10.2 Financial Overview
7.10.3 Product Portfolio
7.10.4 Business Strategies
7.10.5 Recent Developments
7.11 Teva Pharmaceutical Industries Ltd.
7.11.1 Company Overview
7.11.2 Financial Overview
7.11.3 Product Portfolio
7.11.4 Business Strategy
7.11.5 Recent Developments
7.12 UCB SA
7.12.1 Company Overview
7.12.2 Financial Overview
7.12.3 Product Portfolio
7.12.4 Business Strategies
7.12.5 Recent Developments

List of Figures

FIG. 1 Market Segmentation for the Nanomedicine Market
FIG. 2 Global Nanomedicine Market, by Application and Geography, 2012 (USD Billion)
FIG. 3 Porter's Five Forces Analysis: Global Nanomedicine Market
FIG. 4 Market Attractiveness Analysis of the Global Nanomedicine Market, by Application
FIG. 5 Global Nanomedicine Market, 2011 – 2019 (USD Billion)
FIG. 6 Global Nanomedicine for Neurology Market, 2011 - 2019 (USD Billion)
FIG. 7 Global Nanomedicine for Cardiovascular Market, 2011 - 2019 (USD Billion)
FIG. 8 Global Nanomedicine for Oncology Market, 2011 - 2019 (USD Billion)
FIG. 9 Global Nanomedicine for Anti-Inflammatory Market, 2011 - 2019 (USD Billion)
FIG. 10 Global Nanomedicine for Anti-Infective Market, 2011 - 2019 (USD Billion)
FIG. 11 Global Nanomedicine Market for Other Applications, 2011 - 2019 (USD Billion)
FIG. 12 Comparative Analysis: Global Nanomedicine Market by Applications, 2012 & 2019 (Value %)
FIG. 13 Comparative Analysis of the Global Nanomedicine Market, by Geography, 2012 & 2019 (%)
FIG. 14 North America Nanomedicine Market, 2011 - 2019 (USD Billion)
FIG. 15 Europe Nanomedicine Market, 2011 - 2019 (USD Billion)
FIG. 16 Asia-Pacific Nanomedicine Market, 2011 - 2019 (USD Billion)
FIG. 17 Rest of the World Nanomedicine Market, 2011 - 2019 (USD Billion)
FIG. 18 Abbott Laboratories: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 19 CombiMatrix Corporation: Annual Sales, 2010 – 2012 (USD Million)
FIG. 20 Celgene Corporation: Annual Sales, 2010 – 2012 (USD Million)
FIG. 21 Covidien Plc.: – Annual Revenue, 2010 – 2012 (USD Million)
FIG. 22 GE Healthcare: Annual Revenue, 2010–2012 (USD Million)
FIG. 23 Johnson & Johnson: Medical Devices and Diagnostic Business Segment, Annual Revenue, 2010 – 2012 (USD Million)
FIG. 24 Merck & Co. Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 25 Nanosphere Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 26 Pfizer Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 27 Teva Pharmaceutical Industries Ltd.: Annual Revenue, 2010–2012 (USD Million)
FIG. 28 UCB S.A.: Annual Revenue, 2010 – 2012 (USD Million)

List of Tables

TABLE 1 Market Snapshot: Global Nanomedicine Market
TABLE 2 Impact Analysis of the Market Drivers for the Global Nanomedicine Market
TABLE 3 Impact Analysis of the Market Restraints for the Global Nanomedicine Market
TABLE 1 Global Nanomedicine Market, by Applications, 2011 -2019 (USD Billion)
TABLE 2 Global Nanomedicine Market, by Geography, 2011 - 2019 (USD Billion)


Read the full report:
Nanomedicine Market (Neurology, Cardiovascular, Anti-inflammatory, Anti-infective, and Oncology Applications) - Global Industry Analysis, Size, Share,Growth, Trends and Forecast, 2013 - 2019

http://www.reportbuyer.com/pharma_healthcare/drug_delivery/nanomedicine_market_neurology_cardiovascular_anti_inflammatory_anti_infective_oncology_applications_global_industry_analysis_size_share_growth_trends_forecast_2013_2019.html

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer